Back to funds

Fairmount Funds Management LLC

Updated 6 days ago

Managed by Fairmount Funds Management Llc • Latest filing Q3 2026

Portfolio value
$1.6B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.3B
Q1 2026$1.4B
Q2 2026$1.5B
Q3 2026$1.6B

Top holdings

12 positions as of Q3 2026

View filing
O

ORUKA THERAPEUTICS INC

Value
$308.6M
Shares
3.71M
% Port
19.35%
K

KORSANA BIOSCIENCES INC

Value
$291.3M
Shares
9.10M
% Port
18.27%
D

DIANTHUS THERAPEUTICS INC

Value
$223.4M
Shares
2.54M
% Port
14.01%
?
4.N/A

DAMORA THERAPEUTICS INC

Value
$185.4M
Shares
8.71M
% Port
11.63%
C

COGENT BIOSCIENCES INC

Value
$176.2M
Shares
5.50M
% Port
11.05%
V

VIRIDIAN THERAPEUTICS INC

Value
$104.8M
Shares
5.09M
% Port
6.57%
E

ENLIVEN THERAPEUTICS INC

Value
$85.1M
Shares
1.86M
% Port
5.33%
J

JADE BIOSCIENCES INC

Value
$64M
Shares
4.55M
% Port
4.01%
Z

ZENAS BIOPHARMA INC

Value
$64M
Shares
2.37M
% Port
4.01%
C

CRESCENT BIOPHARMA INC.

Value
$52.5M
Shares
3.60M
% Port
3.30%
F

FAETH THERAPEUTICS INC

Value
$21.5M
Shares
722.0K
% Port
1.35%
I

INHIBIKASE THERAPEUTICS INC

Value
$17.7M
Shares
8.63M
% Port
1.11%

Explore